Past and Present Fellows' Accomplishments

Dr. Santos

 

 

Dr. Lourdes Santos was the first NYU Langone Cardiovascular Prevention fellow and she set the pace for future fellows with her extraordinary dedication and accomplishments. She became a diplomat of the American Board of Clinical Lipidology and passed the qualifying exam for a Specialist in Clinical Hypertension. She helped to establish the NYU Langone Cardiovascular Prevention Research registry and worked on a number of research projects during her training. She was awarded the “Young Investigator of the Year Award” by the National Lipid Association for her project investigating the recognition of familial hyperlipidemia in an internal medicine practice.

Since completing her fellowship, Dr. Santos has returned to the Philippines to continue her focus on cardiovascular disease prevention. She serves on the Board of Directors of the Philippine Lipid Atherosclerosis Society. In this capacity, she is helping to update the Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines and is also heading the technical research committee for the 2014 guidelines. She lectures throughout her country about dyslipidemia as well as lecturing in Hong Kong, Malaysia and Taiwan. Dr. Santos teaches clinical lipidology to cardiology fellows and medical students at the Philippines-Philippine General Hospital and continues to be active in the training of the cardiology fellows and medical students. Dr. Santos serves as the Philippine Collaborator (under mentorship of Dr. Rody Sy) on an International Atherosclerosis Society Study that is looking into the existing health services, facilities and resources for the care of Familial Hypercholesterolemia in Asia-Pacific countries, South Africa and Brazil.

 
Dr. Tully  

Dr. Lisa Tully was the second NYU Langone Cardiovascular Prevention fellow and she is currently a NYU Langone fellow of cardiovascular disease. She is a diplomat of the American Board of Clinic Lipidology. During her training, Dr. Tully performed an extensive analysis of our preventive cardiology research registry which led to a major publication demonstrating that patients undergoing cardiovascular intervention have suboptimal control of cardiovascular risk factors. She also has been involved in the development and implementation of the IMPACT trial, a behavioral clinical trial in patients undergoing cardiovascular procedures. She plans to pursue a career in general non-invasive cardiology with a focus in preventive cardiology and lipidology.

 
Dr. Amita Singh  

During her year as the NYU Prevention fellow, Dr. Amita Singh published three review articles on a variety of topics related to the field including 24 hour ambulatory blood pressure monitoring, the treatment of hypertriglyceridemia and strict glycemic control in type 2 diabetics to prevent macro vascular events. She conducted independent research in conjunction with the bariatric group and presented data on 5-year follow-up in laparoscopic gastric banding at the 2013 ACC meeting in San Francisco for both oral and poster presentations, the latter of which won an award for one of the top trainee abstract posters in her category. Dr. Singh presented two posters at the National Lipid Association meeting in Las Vegas in June 2013 based upon patients she met in the Bellevue Lipid Clinic. She is a diplomat of the American Board of Clinic Lipidology and is currently in her second year of cardiology fellowship at University of Chicago where she is Chief fellow. She has two articles being published in 2014 based upon work she started while at NYU. The first article explores statin combination therapies (Endocrinology and Metabolism Clinics) and the second provides insights from a meta-analysis of radomized trials on the efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention (Open Heart 2014).

 

Dr. Joaquin Carral

 

 

 

Dr. Joaquin Carral Gomez is starting a career in primary care with a focus on preventive cardiology and lipidology in Washington, D.C. During his training, he presented an abstract in the National Lipid Association Scientific Session in Orlando Florida and gave a talk for the International Society on Hypertension in Blacks. He was also instrumental in developing educational hand-outs for patients about ideal heart healthy diets. Dr. Carral Gomez also co-facilitated two sessions on Stress Reduction for Patient Care Providers at Montefiore Hospital and at Mt. Sinai Roosevelt Hospital, and plans to continue to work on patient education on cardiovascular health for English and Spanish speaking patients.

 
Bora Toklu, MD  

During his year as preventive cardiology fellow, Dr. Bora Toklu helped with the expansion of the preventive cardiology consult services offered to cardiac electrophysiology and stroke services at NYU Langone Medical Center.  Dr. Toklu completed the National Lipid Association’s Lipid Academy course and participated in the European Atherosclerosis Society’s Advanced Course in Clinical Lipidology and Cardiovascular Prevention.  In addition, he passed exams for the American Board of Clinical Lipidology and the American Society of Hypertension’s Board exam for Clinical Hypertension Specialist.   
 
As preventive cardiology fellow, he participated in 10 peer-reviewed journal publications. One of these publications evaluated the safety and the efficacy of β-blockers in acute MI. Dr. Toklu also participated in five poster presentations given at the National Lipid Association, American Society of Preventive Cardiology, American Heart Association and Transcatheter Cardiovascular Therapeutics national conferences. One of these poster presentations won a top 50 poster award and evaluated clinical outcomes in patients with diabetes undergoing PCI compared to CABG surgery in a systematic meta-analysis of randomized controlled trials. Dr. Toklu is currently a cardiology fellow at Mount Sinai Beth Israel Hospital.

 
 

During his year as preventive cardiology fellow, Dr. Matthew Weiss completed training courses and certification examinations offered by the National Lipid Association, the American Board of Clinical Lipidology, and the American Society of Hypertension.

Dr. Weiss presented posters at prestigious conferences in the U.S. and in Europe including at the Annual NLA Scientific Sessions and at the European Atherosclerosis Society meetings. He has published several abstracts related to his work on Lp(a) and advanced therapies for homozygous familial hypercholesterolemia. He coauthored an upcoming book chapter on the diagnosis and management of complex dyslipidemias and published research related to Type II Myocardial Infarction. He has submitted manuscripts on advanced and atypical cardiovascular disease and Lp(a)-related abnormalities as well as antidiabetic medications and their effects on heart failure.

Dr. Weiss continues his training in Cardiology as a fellow of cardiovascular disease at The Mount Sinai Hospital in New York City. 

 
Tony Matthews, MD  

Dr. Tony Mathews is the 7th Preventive Cardiology Fellow to graduate from our training program. He completed training courses and certification examinations offered by the National Lipid Association and is a diplomat of American Board of Clinical Lipidology.

During his year as the Preventive Cardiology fellow Dr. Mathews presented a poster on the results of the IMPACT trial and achievement of LDL and Non-HDL goals in the subjects enrolled in the IMPACT trial. He helped co-author a book chapter on the role and appropriate utilization of registered dietitians and nutritionists in the primary care setting. He worked on a quality improvement project that demonstrated that an electronic medical record (EMR) based heart failure pathway for hospitalized patients has led to lower 30 day re-admissions, shorter length of stay and improved diuresis in the patients admitted with heart failure at NYU. The manuscript for this study is currently under preparation. His current undertaking includes a cost effectiveness analysis of a newly proposed, cardiovascular disease outcome focused, algorithm for selection of diabetic medications comparing it to the traditional algorithm which relied more on effectiveness in lowering blood glucose and upfront cost. He is currently designing a trial to compare the effectiveness of an RNA-based peripheral blood test versus a stress echocardiogram in detecting coronary artery disease in non-diabetics.

Dr. Tony Mathews plans to stay on at NYU as a Hospitalist Scholar, building on work he started on during his year as the Preventive Cardiology Fellow with a focus on cost-effectiveness and outcomes research in cardiovascular disease prevention.